Pude Pharmaceutical

Shanxi Pude Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company that specializes in the development and manufacture of high-quality injectable drugs. Established in 1994 and based in Datong, Shanxi, the company became a wholly-owned subsidiary of Harbin Gloria Pharmaceuticals in 2015. Pude's product portfolio is diverse, covering therapeutic areas such as cardiovascular disease, oncology, infectious diseases, and clinical nutrition. The company is particularly renowned for its large-scale production of lyophilized powder for injection, operating multiple state-of-the-art GMP-certified facilities. Pude Pharmaceutical plays a critical role in the Chinese healthcare market by providing essential generic and specialty parenteral medications.